SEC Form 4/A · accession 0001179110-17-014957
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Miles D White
Officer — Chairman and CEO · Director
Period of report
Feb 17, 2017
Accepted (ET)
Dec 5, 2017 · 5:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1,F2 | Feb 17, 2017 | A | 92,342 | $0.00 | A | 3,207,105 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- F2This Form 4/A amends the total amount of Abbott shares beneficially owned to include 4,836 shares held in the Judith S. White Living Trust. The reporting person was appointed trustee of the trust on January 16, 2017 and is the beneficiary of the shares in the trust.